Sirtuin2 enhances the tumoricidal function of liver natural killer cells in a mouse hepatocellular carcinoma model

Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering

(2018) May Daher et al.   CURRENT OPINION IN IMMUNOLOGY

Kbtbd2 inhibits the cytotoxic activity of immortalized NK cells through down-regulating mTOR signaling in a mouse hepatocellular carcinoma model

(2018) Kai Dai et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

SIRT2 Inhibition Confers Neuroprotection by Downregulation of FOXO3a and MAPK Signaling Pathways in Ischemic Stroke

(2018) David T. She et al.   MOLECULAR NEUROBIOLOGY

Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma

(2018) Min Yu et al.   MOLECULAR THERAPY

The immunology of hepatocellular carcinoma

(2018) Marc Ringelhan et al.   NATURE IMMUNOLOGY

An Unbiased Linkage Approach Reveals That the p53 Pathway Is Coupled to NK Cell Maturation

(2017) Roxanne Collin et al.   JOURNAL OF IMMUNOLOGY

Engineering Natural Killer Cells for Cancer Immunotherapy

(2017) Katayoun Rezvani et al.   MOLECULAR THERAPY

Increased expression of SIRT2 is a novel marker of cellular senescence and is dependent on wild type p53 status

(2016) Tarique Anwar et al.   CELL CYCLE

Liver-infiltrating CD11b−CD27− NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression

(2016) Qiong-Fang Zhang et al.   Cellular & Molecular Immunology

Who watches the watchmen? Regulation of the expression and activity of sirtuins

(2016) Marcin Buler et al.   FASEB JOURNAL

SIRT2 mediates multidrug resistance in acute myelogenous leukemia cells via ERK1/2 signaling pathway

(2015) HUA XU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer

(2015) Katayoun Rezvani et al.   Frontiers in Immunology

Sirt2 induces C2C12 myoblasts proliferation by activation of the ERK1/2 pathway

(2014) Guofang Wu et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

CD27 Defines Phenotypically and Functionally Different Human NK Cell Subsets

(2014) M. T. M. Vossen et al.   JOURNAL OF IMMUNOLOGY

SIRT2 Regulates LPS-Induced Renal Tubular CXCL2 and CCL2 Expression

(2014) Y. J. Jung et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Differential expression of sirtuin family members in the developing, adult, and aged rat brain

(2014) Elena Sidorova-Darmos et al.   Frontiers in Aging Neuroscience

Subsets of human natural killer cells and their regulatory effects

(2013) Binqing Fu et al.   IMMUNOLOGY

Sirtuins in stress response: guardians of the genome

(2013) L Bosch-Presegué et al.   ONCOGENE

Resveratrol Inhibits CD4+ T Cell Activation by Enhancing the Expression and Activity of Sirt1

(2013) Ting Zou et al.   PLoS One

Three Novel Acetylation Sites in the Foxp3 Transcription Factor Regulate the Suppressive Activity of Regulatory T Cells

(2012) H.-S. Kwon et al.   JOURNAL OF IMMUNOLOGY

Sirtuin-1 Targeting Promotes Foxp3+ T-Regulatory Cell Function and Prolongs Allograft Survival

(2011) U. H. Beier et al.   MOLECULAR AND CELLULAR BIOLOGY

Rapid Temporal Control of Foxp3 Protein Degradation by Sirtuin-1

(2011) Jorg van Loosdregt et al.   PLoS One

Immune responses to malignancies

(2010) Theresa L. Whiteside   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice

(2009) Jinping Zhang et al.   JOURNAL OF CLINICAL INVESTIGATION

CD94 Defines Phenotypically and Functionally Distinct Mouse NK Cell Subsets

(2009) J. Yu et al.   JOURNAL OF IMMUNOLOGY